Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Eur Urol. 2022 Sep 15;83(1):29–38. doi: 10.1016/j.eururo.2022.08.028

Fig. 6 –

Fig. 6 –

Risk stratification for confirmatory germline genetic testing following prostate tumor-only sequencing. a Clinically actionable genes were defined as cancer susceptibility genes with moderate or high penetrance or those with published medical management guidelines (see Supplementary Table 1). b RCC genes are genes associated with hereditary renal cell carcinoma (RCC) syndromes.